These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
515 related articles for article (PubMed ID: 29682089)
1. Large-scale analysis of Croes L; Beyens M; Fransen E; Ibrahim J; Vanden Berghe W; Suls A; Peeters M; Pauwels P; Van Camp G; Op de Beeck K Clin Epigenetics; 2018; 10():51. PubMed ID: 29682089 [TBL] [Abstract][Full Text] [Related]
2. DFNA5 promoter methylation a marker for breast tumorigenesis. Croes L; de Beeck KO; Pauwels P; Vanden Berghe W; Peeters M; Fransen E; Van Camp G Oncotarget; 2017 May; 8(19):31948-31958. PubMed ID: 28404884 [TBL] [Abstract][Full Text] [Related]
3. Region-specific glucocorticoid receptor promoter methylation has both positive and negative prognostic value in patients with estrogen receptor-positive breast cancer. Snider H; Villavarajan B; Peng Y; Shepherd LE; Robinson AC; Mueller CR Clin Epigenetics; 2019 Nov; 11(1):155. PubMed ID: 31675993 [TBL] [Abstract][Full Text] [Related]
4. Methylation analysis of Gasdermin E shows great promise as a biomarker for colorectal cancer. Ibrahim J; Op de Beeck K; Fransen E; Croes L; Beyens M; Suls A; Vanden Berghe W; Peeters M; Van Camp G Cancer Med; 2019 May; 8(5):2133-2145. PubMed ID: 30993897 [TBL] [Abstract][Full Text] [Related]
5. Methylation of the DFNA5 increases risk of lymph node metastasis in human breast cancer. Kim MS; Lebron C; Nagpal JK; Chae YK; Chang X; Huang Y; Chuang T; Yamashita K; Trink B; Ratovitski EA; Califano JA; Sidransky D Biochem Biophys Res Commun; 2008 May; 370(1):38-43. PubMed ID: 18346456 [TBL] [Abstract][Full Text] [Related]
6. Correlation between CpG methylation profiles and hormone receptor status in breast cancers. Feng W; Shen L; Wen S; Rosen DG; Jelinek J; Hu X; Huan S; Huang M; Liu J; Sahin AA; Hunt KK; Bast RC; Shen Y; Issa JP; Yu Y Breast Cancer Res; 2007; 9(4):R57. PubMed ID: 17764565 [TBL] [Abstract][Full Text] [Related]
7. CpG island methylation profile of estrogen receptor alpha in Iranian females with triple negative or non-triple negative breast cancer: new marker of poor prognosis. Ramezani F; Salami S; Omrani MD; Maleki D Asian Pac J Cancer Prev; 2012; 13(2):451-7. PubMed ID: 22524805 [TBL] [Abstract][Full Text] [Related]
8. Promoter hypermethylation in ductal carcinoma in situ of the male breast. Vermeulen MA; van Deurzen CHM; Doebar SC; de Leng WWJ; Martens JWM; van Diest PJ; Moelans CB Endocr Relat Cancer; 2019 Jun; 26(6):575-584. PubMed ID: 30921768 [TBL] [Abstract][Full Text] [Related]
9. Aberrant promoter methylation and tumor suppressive activity of the DFNA5 gene in colorectal carcinoma. Kim MS; Chang X; Yamashita K; Nagpal JK; Baek JH; Wu G; Trink B; Ratovitski EA; Mori M; Sidransky D Oncogene; 2008 Jun; 27(25):3624-34. PubMed ID: 18223688 [TBL] [Abstract][Full Text] [Related]
10. CDH1 promoter hypermethylation and E-cadherin protein expression in infiltrating breast cancer. Caldeira JR; Prando EC; Quevedo FC; Neto FA; Rainho CA; Rogatto SR BMC Cancer; 2006 Mar; 6():48. PubMed ID: 16512896 [TBL] [Abstract][Full Text] [Related]
11. DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression. Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Senchenko VN; Kazubskaya TP; Kushlinskii NE; Dmitriev AA; Braga EA Gene; 2017 Mar; 604():1-8. PubMed ID: 27998789 [TBL] [Abstract][Full Text] [Related]
12. DNA methylation mediated silencing of microRNA-874 is a promising diagnosis and prognostic marker in breast cancer. Zhang L; Yan DL; Yang F; Wang DD; Chen X; Wu JZ; Tang JH; Xia WJ Oncotarget; 2017 Jul; 8(28):45496-45505. PubMed ID: 28525377 [TBL] [Abstract][Full Text] [Related]
13. Physical activity and breast cancer survival: an epigenetic link through reduced methylation of a tumor suppressor gene L3MBTL1. Zeng H; Irwin ML; Lu L; Risch H; Mayne S; Mu L; Deng Q; Scarampi L; Mitidieri M; Katsaros D; Yu H Breast Cancer Res Treat; 2012 May; 133(1):127-35. PubMed ID: 21837478 [TBL] [Abstract][Full Text] [Related]
14. A seven-DNA methylation signature as a novel prognostic biomarker in breast cancer. Tao C; Luo R; Song J; Zhang W; Ran L J Cell Biochem; 2020 Mar; 121(3):2385-2393. PubMed ID: 31646666 [TBL] [Abstract][Full Text] [Related]
15. Protein expression and methylation of MGMT, a DNA repair gene and their correlation with clinicopathological parameters in invasive ductal carcinoma of the breast. Asiaf A; Ahmad ST; Malik AA; Aziz SA; Rasool Z; Masood A; Zargar MA Tumour Biol; 2015 Aug; 36(8):6485-96. PubMed ID: 25820821 [TBL] [Abstract][Full Text] [Related]
16. Downregulation of DNAJC10 (ERDJ5) is associated with poor survival in breast cancer. Acun T; Senses KM Breast Cancer; 2020 May; 27(3):483-489. PubMed ID: 31902119 [TBL] [Abstract][Full Text] [Related]
17. CpG promoter methylation of the ALKBH3 alkylation repair gene in breast cancer. Stefansson OA; Hermanowicz S; van der Horst J; Hilmarsdottir H; Staszczak Z; Jonasson JG; Tryggvadottir L; Gudjonsson T; Sigurdsson S BMC Cancer; 2017 Jul; 17(1):469. PubMed ID: 28679371 [TBL] [Abstract][Full Text] [Related]
18. Frequent epigenetic inactivation of the receptor tyrosine kinase EphA5 by promoter methylation in human breast cancer. Fu DY; Wang ZM; Wang BL; Chen L; Yang WT; Shen ZZ; Huang W; Shao ZM Hum Pathol; 2010 Jan; 41(1):48-58. PubMed ID: 19733895 [TBL] [Abstract][Full Text] [Related]
19. Methylation of the DFNA5 gene is frequently detected in colorectal cancer. Yokomizo K; Harada Y; Kijima K; Shinmura K; Sakata M; Sakuraba K; Kitamura Y; Shirahata A; Goto T; Mizukami H; Saito M; Kigawa G; Nemoto H; Hibi K Anticancer Res; 2012 Apr; 32(4):1319-22. PubMed ID: 22493364 [TBL] [Abstract][Full Text] [Related]
20. CpG island methylator phenotype of multigene in serum of sporadic breast carcinoma. Jing F; Yuping W; Yong C; Jie L; Jun L; Xuanbing T; Lihua H Tumour Biol; 2010 Aug; 31(4):321-31. PubMed ID: 20490964 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]